{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:44:28Z","timestamp":1790081068655,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,5]],"date-time":"2016-01-05T00:00:00Z","timestamp":1451952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jdsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jdermsci.2015.12.009","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T17:46:05Z","timestamp":1450892765000},"page":"153-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell\u2013Th17 cell axis in psoriasis"],"prefix":"10.1016","volume":"81","author":[{"given":"Paola","family":"Lovato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne","family":"Norsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Tokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads A.","family":"R\u00f8pke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2015.12.009_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00403-012-1214-8","article-title":"German S3-guidelines on the treatment of psoriasis vulgaris (short version)","volume":"304","author":"Nast","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies","volume":"60","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","article-title":"1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells","volume":"178","author":"Penna","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0006-291X(02)02262-3","article-title":"Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways","volume":"297","author":"Xing","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0040","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jsbmb.2004.03.039","article-title":"Gene expression profiles in dendritic cells conditioned by 1alpha,25-dihydroxyvitamin D3 analog","volume":"89\u201390","author":"Griffin","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1440-1711.2001.01023.x","article-title":"Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids","volume":"79","author":"Refojo","year":"2001","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0050","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids\u2014new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.immunol.18.1.309","article-title":"Glucocorticoids in T cell development and function*","volume":"18","author":"Ashwell","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0060","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1177\/1352458510379611","article-title":"Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis","volume":"16","author":"Bartosik-Psujek","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0065","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.107.127209","article-title":"Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1\/Th17 to a Th2 and regulatory T cell profile","volume":"324","author":"Daniel","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0075","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.4049\/jimmunol.179.9.6273","article-title":"Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+ CD25+ cells in the draining lymph nodes","volume":"179","author":"Gorman","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2567.2010.03315.x","article-title":"Topical 1,25-dihydroxyvitamin D3 subverts the priming ability of draining lymph node dendritic cells","volume":"131","author":"Gorman","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0085","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.167.9.4974","article-title":"1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells","volume":"167","author":"Boonstra","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/art.25043","article-title":"1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis","volume":"62","author":"Colin","year":"2010","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0095","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.4049\/jimmunol.181.12.8504","article-title":"IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes","volume":"181","author":"Peric","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0100","doi-asserted-by":"crossref","first-page":"e6340","DOI":"10.1371\/journal.pone.0006340","article-title":"Vitamin D analogs differentially control antimicrobial peptide\/alarmin expression in psoriasis","volume":"4","author":"Peric","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0105","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/jid.2011.486","article-title":"Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 alarmins psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis","volume":"132","author":"Hegyi","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2133.1998.02461.x","article-title":"Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy","volume":"139","author":"Kragballe","year":"1998","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000066440","article-title":"A new calcipotriol\/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris","volume":"205","author":"Kaufmann","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0120","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mjd.2003.130","article-title":"Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis","volume":"48","author":"Papp","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/00015550252948194","article-title":"A new calcipotriol\/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris","volume":"82","author":"Douglas","year":"2002","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2008.04.027","article-title":"A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial","volume":"59","author":"Jemec","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2008.08927.x","article-title":"A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized double-blind, controlled trial","volume":"160","author":"Van De Kerkhof","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/09546630903214175","article-title":"Treatment of plaque psoriasis with the two-compound product calcipotriol\/betamethasone dipropionate versus both monotherapies: an immunohistochemical study","volume":"21","author":"van","year":"2010","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0145","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.0906-6705.2004.00151.x","article-title":"The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis","volume":"13","author":"Vissers","year":"2004","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0150","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.4049\/jimmunol.1101211","article-title":"1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region","volume":"188","author":"Kang","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0155","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaci.2015.03.032","article-title":"Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis","volume":"136","author":"Czarnowicki","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2010.07.002","article-title":"1alpha,25-dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells","volume":"134","author":"Ikeda","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jdermsci.2015.12.009_bib0165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2014.12.018","article-title":"1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls","volume":"279","author":"Bhargava","year":"2015","journal-title":"J. Neuroimmunol."}],"updated-by":[{"DOI":"10.1016\/j.jdermsci.2016.12.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000}}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181115300943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181115300943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T20:42:22Z","timestamp":1749674542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181115300943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0923181115300943"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.12.009","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jdermsci.2016.12.001","asserted-by":"object"}]},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell\u2013Th17 cell axis in psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}